Outcome in patients undergoing unilateral uterine artery embolization for symptomatic fibroids

Clinical Radiology

Volumn 59, Issue 2, 2004, Pages 186-191

  Nicholson, Tony ^a  

^a HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Conservative management; Fibroid embolization; Unilateral

Indexed keywords

ANALGESIC AGENT; ANTIFIBRINOLYTIC AGENT; CEFUROXIME; GADOLINIUM; GENTAMICIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; IRON; METRONIDAZOLE; MORPHINE SULFATE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

ADULT; ANAMNESIS; ANEMIA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DYSMENORRHEA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SINGLE DRUG DOSE; SYMPTOMATOLOGY; TREATMENT OUTCOME; ULTRASOUND; UTERINE ARTERY EMBOLIZATION; UTERUS MYOMA;

EID: 0742306393     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2003.08.005     Document Type: Article

References (25)

1. Ravina JH, Herbreteau D, Ciaru-Vigneron N, et al. Arterial embolization to treat uterine myomata. Lancet 1995;346:671-2.
2. Bradley E, Reidy J, Forman R, et al. Transcatheter uterine artery embolization to treat large uterine fibroids. BJOG 1998;105:235-40.
3. Goodwin SG, McLucas B, Lee M, et al. Uterine artery embolization for the treatment of uterine leiomyomata: midterm results. J Vasc Interv Radiol 1999;10:1159-65.
4. Spies JB, Scialli AR, Jha RC, et al. Initial results from uterine fibroid embolization for symptomatic leiomyomata. J Vasc Interv Radio 1999;10:1149-57.
5. Hutchins Jr FL, Worthington-Kirsch RL, Berkowitz RP. Selective uterine artery embolization as primary treatment for symptomatic leiomyomata uteri. J Am Assoc Gynecol Laparosc 1999;6:279-84.
6. Pelage JP, Le Dref O, Soyer P, et al. Fibroid related menorrhagia: treatment with superselective embolization of the uterine arteries and mid-term follow up. Radiology 2000;15:428-31.
7. Goodwin SC, Walker WJ. Uterine artery embolization for the treatment of fibroids. Curr Opin Obstet Gynaecol 1998;10: 315-20.
8. Walker W, Green A, Sutton C. Bilateral uterine artery embolization for myomata: results, complications and failures. J Minim Invasive Ther 1999;8:449-54.
9. Walker WJ, Pelage JP. Uterine artery embolization for symptomatic fibroids: clinical results in 400 women with imaging follow up. BJOG 2002;109:1262-72.
10. Pinto I, Chimeno P, Romo A, et al. Uterine fibroids: uterine artery embolization versus hysterectomy for treatment - a prospective randomized and controlled trial. Radiology 2003;226:425-31.
11. Ravina JH, Bouret JM, Fried D, et al. Advantage of preoperative embolization uterine fibroids. Fertil Sexual 1995; 23:45-9.
12. Pelage J-P, Laurent A, Wassef M, et al. Uterine artery embolization in sheep: comparison of acute effects with polyvinyl alcohol particles and calibrated microspheres. Radiology 2002;224:436-45.
13. Binkert CA, Andrews RT, Pavcnik D, et al. Lack of suitability of the rabbit model for particulate uterine artery embolization. J Vasc Interv Radiol 2002;13:609-12.
14. Pelage JP, Le Dref O, Jacob D, et al. Uterine artery embolization: anatomical and technical considerations, indications, results, and complications. J Radiol 2000;81: 1863-74.
15. Nicholson TA, Pelage JP, Ettles DF. Fibroid calcification after uterine artery embolization: ultrasonographic appearance and pathology. J Vasc Interv Radiol 2001;12:443-6.
16. Matson M, Nicholson A, Belli A-M. Anastomoses of the ovarian and uterine arteries: a potential pitfall and cause of failure of uterine embolization. Cardiovasc Interv Radiol 2000;23: 393-6.
17. Siskin G, Eaton L, Steinkin B, et al. Pathological findings in a uterine leiomyoma after bilateral uterine artery embolization. J Vasc Interv Radiol 1999; 10:891-4.
18. Spies JB. Uterine artery embolization: understanding the technical causes of failure. J Vasc Interv Radiol 2003; 14:11-14.
19. West CP, Lumsden MA. Fibroids and menorrhagia. Best Pract Res Clin Obstet Gynaecol 1989;3:357-74.
20. Di Lieto A, De Rosa G, De Falco M, et al. Relationship between ptatelet-derived growth factor expression in leiomyomas and uterine volume changes after gonadotropin-releasing hormone agonist treatment. Hum Pathol 2002;3:220-4.
21. Sozen I, Senturk LM, Arici A. Effect of gonadotropin-releasing hormone agonists on monocyte chemotactic protein-1 production and macrophage infiltration in leiomyomatous uterus. Fertil Steril 2001;76:792-6.
22. Cheng Y-M, Chou C-Y, Huang S-C, et al. Oestrogen deficiency causes DNA damage in uterine leiomyoma cells: a possible mechanism for shrinkage of fibroids by GnRH agonists. BJOG 2001;108:95-102.
23. Makarainen L, Ylikorkala O. Primary and myoma-associated menorrhagia: role of prostaglandins and effects of ibuprofen. BJOG 1986;93:974-8.
24. Aitokallio-Tallberg A, Viinikka L, Ylikorkala O. Urinary 6-keto-prostaglandin F(1a) in patients with gynaecological tumours. Cancer Lett 1987;34:201-6.
25. McLucas B, Reed RA, Goodwin S, et al. Outcomes following unilateral uterine artery embolization. Br J Radiol 2002;75: 122-6.